NCT05160740View on ClinicalTrials.gov

Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer

NARecruitingINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2025

Conditions
Liver Cancer
Interventions
DRUG

Indocyanine green for injection

ICG will be injected to participants preoperatively for molecular fluorescence image

Trial Locations (1)

510282

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
lead

Zhujiang Hospital

OTHER